"Bei Asklepios steht der Mensch im Mittelpunkt. Unsere Mitarbeiterinnen und Mitarbeiter behandeln in unseren Klinken und Lehrkrankenhäusern bundesweit pro Jahr mehr als zwei Millionen Patientinnen und Patienten auf höchstem medizinischen Niveau nach höchsten Qualitätsstandards. Dabei verfolgen wir stets den Anspruch, jeder Patientin und jedem Patienten eine bestmögliche Behandlung in einem jederzeit sicheren Umfeld bei gleichzeitig persönlicher Zuwendung zukommen zulassen. Ob Krankenhaus der Maximalversorgung, spezialisierte Fach- oder Rehaklinik, bei uns werden Sie von hochqualifizierten Fachkräften nach modernsten medizinischen Standards versorgt."

During the past decade, Asklepios Klinik Barmbek conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Asklepios Klinik Barmbek" #1 sponsor was "ResMed" with 3 trials, followed by "Abbott" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Bürgerhospital Frankfurt" with 2 trials sponsored and "University Hospital, Essen" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asklepios Klinik Barmbek" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Altona Children's Hospital" with 1 trials as a collaborator, "Asklepios Kliniken GmbH & Co. KGaA" with 1 trials as a collaborator, "Asklepios Kliniken Hamburg GmbH" with 1 trials as a collaborator and "Asklepios proresearch" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Asklepios Klinik Barmbek" are "Stroke" (4 trials), "Atrial Fibrillation" (3 trials), "Heart Failure" (3 trials), "Coronary Artery Disease" (2 trials) and "Premature Birth" (2 trials). Many other conditions were trialed in "Asklepios Klinik Barmbek" in a lesser frequency.

Most popular intervention types in "Asklepios Klinik Barmbek" are "Drug" (11 trials), "Device" (8 trials), "Other" (4 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atrasentan" (2 trials), "ASA 100 mg" (1 trials), "Anticoagulation Agents (Edoxaban and/or high dose LMWH)" (1 trials), "Apixaban" (1 trials) and "Blood pressure management policies" (1 trials). Other intervention names were less common.

The vast majority of trials in "Asklepios Klinik Barmbek" are 24 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Asklepios Klinik Barmbek". 2 are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Asklepios Klinik Barmbek, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Asklepios Klinik Barmbek, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".